Received: 25 March 2020
Accepted: 18 June 2020
First Online: 24 June 2020
Ethics approval and consent to participate
: Patient derived CRC tumor tissue samples were collected under a Duke Institutional Review Board (IRB) approved protocol (Pro00002435). All participants provided written informed consent to participate in the study. All in vivo mouse experiments were performed in accordance with the animal guidelines and with the approval of the Institutional Animal Care and Use committee (IACUC) at the Duke University Medical Center.
: Not applicable.
: The authors declare that they have no competing interests.